Table 1.
Patient Demographics and Outcomes
| Number = 13 (*Mean) | Percentage (%) | |
|---|---|---|
| Gender | ||
| Male | 5 | 38.46 |
| Female | 8 | 61.54 |
| Age* | (69) | - |
| BMI* | (28.55) | - |
| ASA score | ||
| 3 | 8 | 61.54 |
| 4 | 5 | 38.46 |
| Primary Cause of End Stage Renal Disease | ||
| Hypertension | 3 | 23.08 |
| Diabetes mellitus | 7 | 53.85 |
| Polycystic kidney disease | 1 | 7.7 |
| FSGS | 1 | 7.7 |
| Lupus nephritis | 1 | 7.7 |
| Medical Comorbidities | ||
| Hypertension | 11 | 84.62 |
| Diabetes mellitus | 7 | 53.85 |
| Atrial fibrillation | 2 | 15.38 |
| Myocardial infarction | 4 | 30.77 |
| Stroke | 2 | 15.38 |
| COPD | 1 | 7.7 |
| Pulmonary hypertension | 2 | 15.38 |
| Sever aortic valve stenosis | 1 | 7.7 |
| Bronchial asthma | 1 | 7.7 |
| SLE | 1 | 7.7 |
| Hypothyroidism | 3 | 23.08 |
| Outcomes | ||
| PDC exit site infection | 3 | 23.08 |
| PDC removal | 3 | 23.08 |
| Mortality | 1 | 7.7 |
| Follow up* in months | (22.3) | - |
* Mean was used instead of the number patient.
BMI, Body Mass Index; ASA, American Society of Anesthesiology; FSGS, Focal segmental glomerulosclerosis; COPD, Chronic obstructive pulmonary disease; SLE, Systemic Lupus Erythematosus; PDC, Peritoneal Dialysis Catheter.